Deutsche Bank Says the Strong MLPs Will Survive: 4 Top Picks for 2016
With strong sponsorships, and well thought out capital expenditure plans, these MLPs can fight their way through to better days and come out perhaps even stronger.
All Work
Lee Jackson
4 Big Loser Stocks of 2015 That Could End Up 2016’s Biggest Winners
While there is no guarantee that any of these stocks trade higher, the mere fact that they have come out of the chute roaring this year could be big.
China Slowdown Could Weigh on Tech: 3 Top Stocks to Buy for 2016
Here are three of the top technology picks from RBC. They all generate solid revenues and have catalysts in front of them for 2016 and beyond that can continue to drive share price.
4 Top Merrill Lynch Dividend Energy Stocks to Buy for Big Upside in 2016
There is still a long way to go for the energy sector, but investors willing to carve out some capital and plan on holding positions for up to 18 months could be well rewarded.
3 Restaurant Stocks That Could Benefit From Ongoing Chipotle Troubles
All these concepts have the ability to lure away the Chipotle customer, because they all have menu items that could appeal to that consumer.
SunTrust Says Buy These 2 FANG Stocks Now on Huge Market Pullback
A new research report from SunTrust Robinson Humphrey makes the case for two of the FANG stocks, plus a very contrarian third pick.
4 Safe Dividend Stocks to Buy as 2016 Starts With Market Rout
One great move is to look for safe stocks that pay solid dividends. That often means companies where the demand rarely drops, despite economic and market conditions.
4 Merrill Lynch Cash-Rich Dividend Technology Stocks to Buy for 2016
Technology should remain a sector to own this year, and these cash-rich sector leaders make good sense for growth portfolios looking for an income kicker.
Top Biotech Stock Favorites to Buy With Up to 100% Upside Potential
Like others on Wall Street, the analysts at the specialty biotech and health care boutique firm Leerink see 2016 as a year with some uncertainty.
Utilities Remain a Safe Dividend Buy for Income Investors After a Lousy 2015
While the big money made in utility stocks over the past five years is likely over, some of these top stocks still make good sense in a conservative growth and income portfolios.
Insider Buying Steady as 2015 Winds Down: Prospect Capital, comScore, Angie’s List, ONEOK and More
The ups and downs of 2015 didn’t keep executives and 10% institutional owners from buying shares, and this past week, which marked the end of 2015, was no exception.
Baird Is Bullish on 3 Very Hot Stocks Poised for 2016 Potential Upside
Baird has maintained Outperform ratings on three top companies that have reported outstanding numbers and had positive catalysts. All three could be solid additions to aggressive growth portfolios for 2016.
Merrill Lynch Has 4 Big 2015 Losers to Buy for Big Potential 2016 Gains
24/7 Wall St. screened the Merrill Lynch research database for stocks that performed well in 2014 but met with not only selling this year, but a degree of scorn from some of the analysts…
RBC Out With Top Specialty Pharmaceutical Stocks to Buy for 2016
These specialty pharmaceutical stocks have tremendous upside potential for 2016 and could be offering investors outstanding entry points at current trading levels.
4 Blue Chip Stocks to Buy Now as Dollar Strength May Fade in 2016
24/7 Wall St. screened the Merrill Lynch database for stocks that were rated Buy and that also did a significant amount of their sales and business overseas.
Energy Short Interest Highest Ever: Stick With 3 Large Cap Dividend Leaders in 2016
Oil won’t stay this low forever. In the meantime, it just makes sense for investors to stay with the large cap leaders that have survived these market downturns in the past.
4 Chip Equipment Companies That Could Benefit From Big 2016 Spending
While these stocks are only suitable for very aggressive risk tolerant accounts, the anticipated increase in spending in 2016 could make a solid difference to the top and bottom lines of these well-run companies.
Merrill Lynch Has 4 Large Cap Pharmaceutical Dividend Stocks for 2016
These companies all provide drugs and medical devices that help hundreds of thousands of people daily lead a better life. They make good sense for conservative portfolios looking for income and growth next year.
Could These Hot 2015 Biotech IPOs Be 2016 Buyout Targets?
While there is certainly no guarantee that any of these hot biotech companies is bought, they each offer aggressive accounts big potential upside and have unique products and clinical possibilities going forward.
Insider Buying Strong as Holiday Slows Trading: Prospect Capital, Guidance Software, comScore, Sears, Delta Air and More
One thing is for sure, the insiders and 10% owners did some late shopping and continued to buy stock this past week at a furious pace.